Previous Next

2024-03-29

IL-41 in resistance to Kawasaki disease treatments

Hematology

In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41 levels were significantly increased in children resistant to Kawasaki disease treatments. Serum IL-41 levels were positively correlated with erythrocyte sedimentation rate, C-reactive protein and C-reactive protein/albumin ratio, but negatively correlated with albumin. Total number of fever days and neutrophil/lymphocyte ratio were independent predictors of resistance to intravenous immunoglobulin. 


Source(s) :
Yan Duan et al. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023 Sep:122:110600. ;

Last press reviews


Fibromyalgia and eating disorders: a hidden link?

By Ana Espino | Published on May 13, 2026 | 3 min read<br><br><br>Fi...

Physical exercise and fibromyalgia: moving to hurt less?

By Ana Espino | Published on May 13, 2026 | 4 min read<br><br><br>Fi...

Epilepsy in children: why is there an increased risk of autism ?

By Elodie Vaz | Published on May 13, 2026&nbsp;| 4 min read<br><br><br>...